“Until this quality situation resolves to a meaningful extent, which may entail an entirely new method of regulation, any recommendations by health care practitioners to patients should generally be restricted to verified or tested products. … Among hospitals that do allow dietary supplements in their drug formularies, inclusion should be restricted solely to brands that are USP Verified or third-party tested. … currently, it is the only reasonable measure to ensure safety in terms of quality.”